WADA, world sport’s anti-doping body, will not appeal against the one-month doping sanction levied against tennis world No 2 Iga Swiatek. The Pole recorded a positive test for the banned substance trimetazidine (TMZ) in August.

The World Anti-Doping Agency will not appeal against the ban given to Poland's Iga Swiatek. The five-time major winner tested positive for heart medication trimetazidine (TMZ) in an out-of-competition sample in August 2024.

Iga Swiatek felt satisfaction and hoped for closure after the World Anti-Doping Agency (WADA) said on Monday that it would not appeal her case at sport's highest court.

The men's world No. 1 could face a two-year ban. Here's what to know about the doping proceedings against him so far

The World Anti-Doping Agency (WADA) has decided not to appeal the case of Iga Swiatek, after the tennis player tested positive for trimetazidine (TMZ) due to contaminated melatonin. WADA found no significant fault on Swiatek's part,

Iga Swiatek's one-month suspension for failing a drug test will not be appealed by the World Anti-Doping Agency because her explanation "is plausible," WADA

Iga Swiatek says she can get "a closure" now that the WADA won't appeal the ITIA's ruling in her doping case but also underlines that she expected this outcome all along. While the world No. 2 was on the court playing against Eva Lys at the Australian Open, the WADA announced that they would not lodge an appeal and take her case to the CAS.

WADA released its decision after Iga Swiatek sealed a victory against Eva Lys to reach the Australian Open quarterfinals.

The findings for the world No.2 were released straight after her win over Eva Lys in the fourth round of the Australian Open.